KYTX
Kyverna Therapeutics Inc.

1,038
Mkt Cap
$458.13M
Volume
625.00
52W High
$13.67
52W Low
$1.78
PE Ratio
-2.36
KYTX Fundamentals
Price
$8.63
Prev Close
$7.58
Open
$7.75
50D MA
$8.30
Beta
1.90
Avg. Volume
579,825.13
EPS (Annual)
-$3.64
P/B
2.24
Rev/Employee
$0.00
$165.82
Loading...
Loading...
News
all
press releases
HC Wainwright Analysts Increase Earnings Estimates for KYTX
Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) - HC Wainwright increased their Q1 2026 earnings per share (EPS) estimates for Kyverna Therapeutics in a research report issued to clients and...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Brokers Issue Forecasts for KYTX FY2027 Earnings
Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) - Stock analysts at HC Wainwright issued their FY2027 EPS estimates for shares of Kyverna Therapeutics in a research note issued on Monday, March 30th. HC Wainwright analyst M. Kapoor forecasts that the company will post earnings per share of...
MarketBeat·1d ago
News Placeholder
Kyverna Therapeutics (NASDAQ:KYTX) Announces Earnings Results
Kyverna Therapeutics (NASDAQ:KYTX - Get Free Report) posted its earnings results on Thursday. The company reported ($0.80) earnings per share (EPS) for the quarter, meeting the consensus estimate of...
MarketBeat·6d ago
News Placeholder
Kyverna Therapeutics (KYTX) Expected to Announce Quarterly Earnings on Wednesday
Kyverna Therapeutics (NASDAQ:KYTX) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at...
MarketBeat·7d ago
News Placeholder
Kyverna Therapeutics (NASDAQ:KYTX) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen downgraded Kyverna Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·11d ago
News Placeholder
Kyverna Therapeutics (NASDAQ:KYTX) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Kyverna Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·1mo ago
News Placeholder
Wall Street Zen Downgrades Kyverna Therapeutics (NASDAQ:KYTX) to Sell
Wall Street Zen lowered Kyverna Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·2mo ago
News Placeholder
Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Given Average Rating of "Moderate Buy" by Analysts
Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the five analysts that are covering the stock, Marketbeat.com reports...
MarketBeat·2mo ago
News Placeholder
Kyverna Therapeutics (NASDAQ:KYTX) Upgraded to "Hold" at Wall Street Zen
Wall Street Zen raised shares of Kyverna Therapeutics from a "sell" rating to a "hold" rating in a research report on Sunday...
MarketBeat·3mo ago
News Placeholder
Kyverna Therapeutics (NASDAQ:KYTX) Rating Lowered to "Sell" at Wall Street Zen
Wall Street Zen cut Kyverna Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·3mo ago
<
1
2
...
>

Latest KYTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.